Therapeutic options in mantle cell lymphoma
- PMID: 18297516
- DOI: 10.1080/10428190701851364
Therapeutic options in mantle cell lymphoma
Abstract
Mantle cell lymphoma (MCL) is an aggressive lymphoma requiring intensive chemotherapy +/- autologous stem cell transplantation (SCT) to achieve optimal rates of progression-free survival. Here we review the treatment options for patients with newly-diagnosed or relapsed MCL and discuss recent advances in management, including the role of autologous and allogeneic SCT.
Similar articles
-
Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?Int J Hematol. 2017 Mar;105(3):257-264. doi: 10.1007/s12185-016-2164-2. Epub 2016 Dec 19. Int J Hematol. 2017. PMID: 27995456 Review.
-
Role of allogeneic stem cell transplantation in mantle cell lymphoma.Eur J Haematol. 2015 Apr;94(4):290-7. doi: 10.1111/ejh.12442. Epub 2014 Oct 18. Eur J Haematol. 2015. PMID: 25154430 Free PMC article. Review.
-
Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease.Curr Oncol Rep. 2022 Oct;24(10):1313-1326. doi: 10.1007/s11912-022-01297-x. Epub 2022 May 31. Curr Oncol Rep. 2022. PMID: 35639332 Review.
-
[Treatment for mantle cell lymphoma].Rinsho Ketsueki. 2017;58(10):2026-2032. doi: 10.11406/rinketsu.58.2026. Rinsho Ketsueki. 2017. PMID: 28978845 Japanese.
-
Controversies in lymphoma: the role of hematopoietic cell transplantation for mantle cell lymphoma and peripheral T cell lymphoma.Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):100-7. doi: 10.1016/j.bbmt.2007.10.019. Biol Blood Marrow Transplant. 2008. PMID: 18162229 Review.
Cited by
-
Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.J Immunother. 2009 Sep;32(7):689-702. doi: 10.1097/CJI.0b013e3181ac6138. J Immunother. 2009. PMID: 19561539 Free PMC article.
-
Mantle cell lymphoma: a rare cause for a swollen palate.BMJ Case Rep. 2020 Oct 4;13(10):e238332. doi: 10.1136/bcr-2020-238332. BMJ Case Rep. 2020. PMID: 33012718 Free PMC article.
-
Temsirolimus: In relapsed and/or refractory mantle cell lymphoma.Drugs. 2010 Oct 1;70(14):1819-29. doi: 10.2165/11204940-000000000-00000. Drugs. 2010. PMID: 20836575 Review.
-
Primary mantle-cell non-Hodgkin's lymphoma of the tongue.Int J Hematol. 2008 Sep;88(2):206-208. doi: 10.1007/s12185-008-0142-z. Epub 2008 Jul 16. Int J Hematol. 2008. PMID: 18629601
-
Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.Transl Oncol. 2011 Feb 1;4(1):9-19. doi: 10.1593/tlo.10172. Transl Oncol. 2011. PMID: 21286373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources